PALISADE BIO, INC. (PALI) › Capital ExpendituresPALISADE BIO, INC. (PALI) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $88.4K2010: $76.3K2011: $196.4K2012: $39.2K2013: $125.4K2014: $207.9K2015: $176.3K2016: $98.1K2017: $11.4K2018: $1.7K2020: $6.0K2021: $02022: $10.0K2023: $4.0K2024: $0$02009Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$0-100.0%2023$4.0K-60.0%2022$10.0K—2021$0-100.0%2020$6.0K—2018$1.7K-85.0%2017$11.4K-88.4%2016$98.1K-44.4%2015$176.3K-15.2%2014$207.9K+65.8%2013$125.4K+219.6%2012$39.2K-80.0%2011$196.4K+157.3%2010$76.3K-13.6%2009$88.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share